NN ARBOR, Mich.--(BUSINESS WIRE)--KAI Research, Inc., a wholly owned subsidiary of Altarum Institute, will highlight its latest work around clinical trials and pharmacovigilance at the upcoming Drug Information Association (DIA) Conference, June 14–18, in Washington, DC.
KAI is a full-service contract research organization (CRO) helping pharmaceutical, academic, and federal clients bring innovative drug treatments and interventions to market since 1986.
Help employers find you! Check out all the jobs and post your resume.
